Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Global Health Limited engages in the provision of healthcare services in India. The company primarily offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, musculoskeletal disorders and orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, plastic, aesthetic and reconstructive surgery, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, ayurveda, and dietetics and nutrition. It also offers lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, blood bank and e-ICU services, and health plans, as well as operates pharmacies. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in New Delhi, India.

Revenue projections:

Revenue projections for MEDANTA
Revenue projections for MEDANTA

Revenues for MEDANTA are expected to drop compared to the previous year, which could be a cause for concern for investors. A decline in earnings may negatively impact the company's profitability, leading cautious investors to reconsider their positions, as it often signals challenges in overall financial health.

Financial Ratios:

currentRatio 2.478000
forwardPE 46.806915
debtToEquity 21.188000
earningsGrowth -0.204000
revenueGrowth 0.128000
grossMargins 0.538440
operatingMargins 0.188390
trailingEps 17.910000
forwardEps 23.410000

MEDANTA's current ratio, being 2.478, means the company is well-positioned to meet its short-term debt obligations. This reflects MEDANTA's strong liquidity, as its cash reserves and current assets provide more than enough coverage for its immediate liabilities.
MEDANTA's low Debt-to-Equity ratio suggests the company is minimally leveraged, with limited reliance on debt to finance its operations. This reduced financial risk positions the company for greater stability and financial health, appealing to investors who value conservative financial management.
MEDANTA's low earnings and revenue growth suggest that the company's profits may shrink. This trend could indicate underlying financial struggles and pose challenges for MEDANTA's future profitability.
Global Health Limited's negative gross and operating margins suggest that the company is currently losing money, unable to generate profit from production or operations. This could signal inefficiencies in cost control or a drop in sales.
With MEDANTA's forward EPS higher than its trailing EPS, the company is expected to be more profitable in the current financial year. This signals confidence in MEDANTA's growth potential, as improved earnings are forecasted compared to the prior year's performance.

Price projections:

Price projections for MEDANTA
Price projections for MEDANTA

Global Health Limited's price has consistently remained near the lower edge of projections, suggesting that it is not fully meeting market expectations. This could indicate a need for improved performance or strategies to boost investor confidence.

Recommendation changes over time:

Recommendations trend for MEDANTA
Recommendations trend for MEDANTA


Analysts have been favoring MEDANTA with a buy bias recently, signaling a promising investment opportunity. This optimistic outlook may attract more investors, positioning MEDANTA as a desirable option for those seeking to invest their money in a stable, profitable company with strong growth potential.